← Back to Suven Life Sciences Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

SUVENHealthcare Research, Analytics & Technology

Suven Life Sciences Ltd — Financial Ratios & Key Metrics

₹131.70

-2.75%

P/E RatioN/AxIndustry: 45.95x

ROE-87.22%Return on equity

ROCE-86.96%Return on capital

Debt/Equity0.00Debt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

45.95x

Dividend Yield

0.00%

Market Cap

₹3.93K (Cr)

Sales Growth 5Y

-12.00%

Profit Growth 5Y

-24.19%

EPS Growth 5Y

-14.08%

OPM 5Y Avg

-1086.16%

📉

Price Returns

1 Month

-12.67%

3 Months

-20.96%

6 Months

-26.36%

1 Year

+32.94%

52W Low

₹114

Current

₹132

52W High

₹300

10% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹144

▼ Price below SMA 50 — Bearish

SMA 200

₹197

▼ Long-term downtrend

Volume Signal

242% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Suven Life Sciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Research, Analytics & Technology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.